X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-06-13 | HBIO | Harvard Bioscience Inc | Green James W | CEO | P - Purchase | $2.91 | +10,000 | 3,111,091 | 0% | +$29,100 | ||||||
2024-06-13 | BIOBI | Bio-Rad Laboratories, Inc. | Crowley Michael | EVP, GBL Commercial Operations | S - Sale | $281.91 | -369 | 6,573 | -5% | -$104,023 | ||||||
2024-06-13 | SCND | Scientific Industries Inc | Moore John A | Dir | P - Purchase | $1.47 | +16,300 | 414,590 | +4% | +$24,035 | ||||||
| D | 2024-06-11 | AKYA | Akoya Biosciences, Inc. | McKelligon Brian | Pres, CEO | S - Sale+OE | $2.08 | -7,500 | 224,733 | -3% | -$15,630 | |||||
2024-06-10 | A | Agilent Technologies, Inc. | Grau Dominique | SVP | S - Sale | $133.28 | -15,000 | 102,288 | -13% | -$1,999,262 | ||||||
2024-06-07 | RVTY | Revvity, Inc. | Goldberg Joel S | Please See Remarks | S - Sale | $110.46 | -4,000 | 100,609 | -4% | -$441,844 | ||||||
| D | 2024-06-06 | AKYA | Akoya Biosciences, Inc. | McKelligon Brian | Pres, CEO | S - Sale+OE | $2.01 | -7,500 | 224,733 | -3% | -$15,064 | |||||
2024-06-06 | HBIO | Harvard Bioscience Inc | Green James W | CEO | P - Purchase | $3.07 | +20,000 | 3,101,091 | +1% | +$61,400 | ||||||
| D | 2024-06-03 | A | Agilent Technologies, Inc. | McDonnell Padraig | Pres, CEO | S - Sale+OE | $130.00 | -1,958 | 29,992 | -6% | -$254,540 | |||||
| M | 2024-05-28 | ASTC | Astrotech Corp | Becker James Frank | Dir | P - Purchase | $9.67 | +2,034 | 16,121 | +14% | +$19,675 | |||||
2024-05-28 | WAT | Waters Corp /de/ | Fearon Richard H | Dir | P - Purchase | $332.90 | +1,000 | 1,653 | +153% | +$332,900 | ||||||
2024-05-23 | LAB | Standard Biotools Inc. | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $2.60 | +100,000 | 71,611,233 | 0% | +$260,000 | ||||||
2023-05-23 | ASTC | Astrotech Corp | Hinojosa Jaime | CFO | P - Purchase | $9.49 | +900 | 7,881 | +13% | +$8,541 | ||||||
2024-05-22 | TXG | 10X Genomics, Inc. | McAnear Justin J. | CFO | S - Sale | $24.30 | -2,936 | 146,203 | -2% | -$71,355 | ||||||
2024-05-22 | TXG | 10X Genomics, Inc. | Saxonov Serge | CEO | S - Sale | $24.30 | -4,877 | 1,126,358 | 0% | -$118,529 | ||||||
2024-05-22 | TXG | 10X Genomics, Inc. | Hindson Benjamin J. | See Remarks | S - Sale | $24.30 | -4,087 | 350,055 | -1% | -$99,329 | ||||||
| M | 2024-05-20 | LAB | Standard Biotools Inc. | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $2.57 | +600,000 | 71,511,233 | +1% | +$1,541,795 | |||||
2024-05-20 | PACB | Pacific Biosciences of California, Inc. | Farmer Michele | See Remarks | S - Sale | $2.03 | -5,275 | 211,941 | -2% | -$10,708 | ||||||
| D | 2024-05-20 | AXDX | Accelerate Diagnostics, Inc | Mertz Larry Michael | CTO | S - Sale+OE | $0.88 | -361 | 82,028 | 0% | -$318 | |||||
2024-05-21 | ASTC | Astrotech Corp | Wilkinson Thomas Wiley | Dir | P - Purchase | $9.50 | +1,109 | 20,862 | +6% | +$10,536 | ||||||
| D | 2024-05-16 | MTD | Mettler Toledo International Inc/ | Vadala Shawn | CFO | S - Sale+OE | $1,528.43 | -300 | 4,914 | -6% | -$458,528 | |||||
| M | 2024-05-15 | LAB | Standard Biotools Inc. | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $2.56 | +1,352,072 | 70,911,233 | +2% | +$3,455,544 | |||||
| D | 2024-05-14 | EYPT | Eyepoint Pharmaceuticals, Inc. | Guyer David R | Dir | S - Sale+OE | $12.65 | -11,625 | 5,550 | -68% | -$147,045 | |||||
| D | 2024-05-15 | WAT | Waters Corp /de/ | Kuebler Christopher A | Dir | S - Sale+OE | $361.64 | -4,000 | 14,716 | -21% | -$1,446,560 | |||||
| D | 2024-05-15 | MTD | Mettler Toledo International Inc/ | Keller Gerry | Head of Process Analytics | S - Sale+OE | $1,511.56 | -310 | 6 | -98% | -$468,584 | |||||
| DM | 2024-05-13 | MTD | Mettler Toledo International Inc/ | Vadala Shawn | CFO | S - Sale+OE | $1,475.20 | -2,030 | 4,914 | -29% | -$2,994,661 | |||||
| D | 2024-05-13 | MTD | Mettler Toledo International Inc/ | Salice Thomas P | Dir | S - Sale+OE | $1,490.18 | -1,268 | 53,590 | -2% | -$1,889,551 | |||||
| D | 2024-05-13 | MTD | Mettler Toledo International Inc/ | Magloth Christian | Head of HR | S - Sale+OE | $1,470.97 | -1,100 | 734 | -60% | -$1,618,067 | |||||
2024-05-14 | QTRX | Quanterix Corp | Olson Laurie J | Dir | S - Sale | $16.98 | -1,500 | 13,738 | -10% | -$25,470 | ||||||
2024-05-06 | EYPT | Eyepoint Pharmaceuticals, Inc. | Cormorant Asset Management, LP | 10% | P - Purchase | $11.86 | +850,000 | 8,325,000 | +11% | +$10,081,721 | ||||||
2023-05-03 | BIOBI | Bio-Rad Laboratories, Inc. | Schwartz Steven D | 10% | S - Sale | $463.86 | -320 | 4,461,824 | 0% | -$148,435 | ||||||
2024-04-19 | CTKB | Cytek Biosciences, Inc. | Yan Ming | CTO | S - Sale | $5.87 | -20,000 | 5,988,502 | 0% | -$117,400 | ||||||
2024-04-18 | EYPT | Eyepoint Pharmaceuticals, Inc. | Cormorant Asset Management, LP | 10% | P - Purchase | $18.03 | +581,765 | 7,475,000 | +8% | +$10,489,446 | ||||||
| D | 2024-04-17 | AXDX | Accelerate Diagnostics, Inc | Phillips Jack | CEO | S - Sale+OE | $0.78 | -26,735 | 162,919 | -14% | -$20,853 | |||||
| D | 2024-04-12 | AXDX | Accelerate Diagnostics, Inc | Phillips Jack | CEO | S - Sale+OE | $0.86 | -26,545 | 129,726 | -17% | -$22,829 | |||||
2024-04-09 | CTKB | Cytek Biosciences, Inc. | Yan Ming | CTO | S - Sale | $7.00 | -1,900 | 6,008,502 | 0% | -$13,304 | ||||||
| D | 2024-04-09 | AXDX | Accelerate Diagnostics, Inc | Patience David | CFO | S - Sale+OE | $0.87 | -13,296 | 51,179 | -21% | -$11,568 | |||||
| D | 2024-04-09 | AXDX | Accelerate Diagnostics, Inc | Mertz Larry Michael | CTO | S - Sale+OE | $0.87 | -13,984 | 81,106 | -15% | -$12,166 | |||||
| D | 2024-04-04 | AXDX | Accelerate Diagnostics, Inc | Mertz Larry Michael | CTO | S - Sale+OE | $0.88 | -978 | 54,457 | -2% | -$861 | |||||
| D | 2024-04-04 | AXDX | Accelerate Diagnostics, Inc | Phillips Jack | CEO | S - Sale+OE | $0.88 | -15,887 | 96,343 | -14% | -$13,981 | |||||
| D | 2024-04-01 | QTRX | Quanterix Corp | Olson Laurie J | Dir | S - Sale+OE | $23.50 | -1,000 | 15,238 | -6% | -$23,500 | |||||
2024-03-25 | A | Agilent Technologies, Inc. | Binns Philip | SVP | S - Sale | $147.54 | -2,827 | 9,997 | -22% | -$417,096 | ||||||
| D | 2024-03-20 | AKYA | Akoya Biosciences, Inc. | McKelligon Brian | Pres, CEO | S - Sale+OE | $4.97 | -7,500 | 231,868 | -3% | -$37,243 | |||||
| AD | 2024-03-13 | AKYA | Akoya Biosciences, Inc. | McKelligon Brian | Pres, CEO | S - Sale+OE | $4.94 | -7,500 | 231,868 | -3% | -$37,043 | |||||
| M | 2024-03-18 | CTKB | Cytek Biosciences, Inc. | Yan Ming | CTO | S - Sale | $6.74 | -40,000 | 6,010,402 | -1% | -$269,600 | |||||
2024-03-15 | ASTC | Astrotech Corp | Russler Daniel T Jr | Dir | P - Purchase | $8.42 | +387 | 14,904 | +3% | +$3,259 | ||||||
2023-03-15 | ASTC | Astrotech Corp | McFarland Robert N | Dir | P - Purchase | $8.50 | +1,185 | 10,900 | +12% | +$10,073 | ||||||
| M | 2024-03-13 | ASTC | Astrotech Corp | Becker James Frank | Dir | P - Purchase | $8.20 | +1,488 | 14,087 | +12% | +$12,200 | |||||
2024-03-13 | AKYA | Akoya Biosciences, Inc. | McKelligon Brian | Pres, CEO | S - Sale | $4.94 | -7,500 | 224,368 | -3% | -$37,035 | ||||||
2024-03-12 | ASTC | Astrotech Corp | Russler Daniel T Jr | Dir | P - Purchase | $8.29 | +500 | 14,517 | +4% | +$4,145 | ||||||
2024-03-13 | WAT | Waters Corp /de/ | Baddour Linda | Dir | S - Sale | $355.54 | -500 | 2,250 | -18% | -$177,770 | ||||||
2024-03-13 | ASTC | Astrotech Corp | Wilkinson Thomas Wiley | Dir | P - Purchase | $8.28 | +1,300 | 19,753 | +7% | +$10,765 | ||||||
2024-03-12 | ASTC | Astrotech Corp | Becker James Frank | Dir | P - Purchase | $8.14 | +958 | 12,599 | +8% | +$7,798 | ||||||
2024-03-07 | SEER | Seer, Inc. | Farokhzad Omid | CEO, CHAIR | S - Sale | $2.03 | -52,857 | 1,436,285 | -4% | -$107,421 | ||||||
2024-03-08 | AVTR | Avantor, Inc. | Eck Steven W | SVP, Chief Accounting Officer | S - Sale | $25.63 | -3,685 | 34,406 | -10% | -$94,447 | ||||||
2024-03-08 | A | Agilent Technologies, Inc. | McMullen Michael R. | CEO, Pres | S - Sale | $150.00 | -52,297 | 253,909 | -17% | -$7,844,550 | ||||||
| M | 2024-03-08 | NAUT | Nautilus Biotechnology, Inc. | Patel Sujal M | CEO, Pres,, Secretary, 10% | P - Purchase | $2.87 | +14,474 | 17,158,999 | 0% | +$41,478 | |||||
2024-03-07 | A | Agilent Technologies, Inc. | Gonsalves Rodney | VP, Corporate Controller | S - Sale | $149.00 | -4,828 | 21,370 | -18% | -$719,348 | ||||||
| M | 2024-03-05 | NAUT | Nautilus Biotechnology, Inc. | Patel Sujal M | CEO, Pres,, Secretary, 10% | P - Purchase | $2.79 | +35,526 | 17,144,525 | 0% | +$99,054 | |||||
2024-03-05 | A | Agilent Technologies, Inc. | Fields Heidi | Dir | S - Sale | $144.34 | -1,658 | 54,976 | -3% | -$239,316 | ||||||
| M | 2024-03-04 | LAB | Standard Biotools Inc. | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $2.57 | +251,403 | 23,093,703 | +1% | +$646,169 | |||||
2024-03-06 | PACB | Pacific Biosciences of California, Inc. | Meline David W | Dir | P - Purchase | $4.40 | +40,000 | 40,000 | New | +$176,160 | ||||||
2024-03-04 | PACB | Pacific Biosciences of California, Inc. | Farmer Michele | See Remarks | S - Sale | $4.87 | -2,968 | 217,216 | -1% | -$14,457 | ||||||
2024-03-04 | PACB | Pacific Biosciences of California, Inc. | Van Oene Mark | See Remarks | S - Sale | $4.87 | -9,186 | 1,668,826 | -1% | -$44,745 | ||||||
2024-03-04 | PACB | Pacific Biosciences of California, Inc. | Kim Susan G. | See Remarks | S - Sale | $4.87 | -5,275 | 712,260 | -1% | -$25,695 | ||||||
2024-03-04 | PACB | Pacific Biosciences of California, Inc. | Henry Christian O | See Remarks | S - Sale | $4.87 | -14,177 | 2,596,670 | -1% | -$69,056 | ||||||
2024-03-04 | TXG | 10X Genomics, Inc. | Saxonov Serge | CEO | S - Sale | $44.00 | -4,660 | 1,043,467 | 0% | -$205,021 | ||||||
| D | 2024-03-04 | BRKR | Bruker Corp | Requardt Hermann Fritz | Dir | S - Sale+OE | $90.06 | -15,000 | 23,147 | -39% | -$1,350,898 | |||||
| D | 2024-03-04 | MTD | Mettler Toledo International Inc/ | Magloth Christian | Head of HR | S - Sale+OE | $1,278.73 | -400 | 734 | -35% | -$511,492 | |||||
2024-02-29 | AVTR | Avantor, Inc. | Bramwell James | EVP Sales, Customer Excellence | S - Sale | $24.52 | -4,910 | 96,233 | -5% | -$120,393 | ||||||
2024-02-29 | AVTR | Avantor, Inc. | Couturier Christophe | EVP, AMEA | S - Sale | $24.53 | -13,074 | 83,889 | -13% | -$320,705 | ||||||
| D | 2024-02-28 | BRKR | Bruker Corp | Busse Falko | Pres, BioSpin Group | S - Sale+OE | $85.48 | -28,122 | 32,859 | -46% | -$2,403,890 | |||||
| D | 2024-02-28 | BIOBI | Bio-Rad Laboratories, Inc. | Ernst Timothy S | EVP, GC, Sec | S - Sale+OE | $330.55 | -2,500 | 3,397 | -42% | -$826,375 | |||||
| D | 2024-02-27 | RVTY | Revvity, Inc. | Vohra Tajinder S | Please See Remarks | S - Sale+OE | $105.39 | -7,918 | 26,113 | -23% | -$834,441 | |||||
| D | 2024-02-27 | BIOBI | Bio-Rad Laboratories, Inc. | Crowley Michael | EVP, GBL Commercial Operations | S - Sale+OE | $336.00 | -3,000 | 6,942 | -30% | -$1,008,000 | |||||
| D | 2024-02-26 | AXDX | Accelerate Diagnostics, Inc | Patience David | CFO | S - Sale+OE | $0.96 | -350 | 27,007 | -1% | -$336 | |||||
| D | 2024-02-27 | AVTR | Avantor, Inc. | Bramwell James | EVP Sales, Customer Excellence | S - Sale+OE | $24.49 | -6,203 | 101,143 | -6% | -$151,911 | |||||
| D | 2024-02-23 | MTD | Mettler Toledo International Inc/ | Vadala Shawn | CFO | S - Sale+OE | $1,210.83 | -300 | 4,914 | -6% | -$363,249 | |||||
2024-02-22 | TXG | 10X Genomics, Inc. | Saxonov Serge | CEO | S - Sale | $46.34 | -2,821 | 1,048,127 | 0% | -$130,737 | ||||||
2024-02-22 | TXG | 10X Genomics, Inc. | Hindson Benjamin J. | See Remarks | S - Sale | $46.34 | -2,613 | 283,059 | -1% | -$121,098 | ||||||
2024-02-22 | TXG | 10X Genomics, Inc. | McAnear Justin J. | CFO | S - Sale | $46.34 | -1,865 | 95,240 | -2% | -$86,432 | ||||||
2024-02-23 | RVTY | Revvity, Inc. | Goldberg Joel S | Please See Remarks | S - Sale | $105.13 | -835 | 104,609 | -1% | -$87,784 | ||||||
2024-02-23 | RVTY | Revvity, Inc. | Singh Prahlad R. | Please See Remarks | S - Sale | $105.13 | -1,144 | 127,358 | -1% | -$120,269 | ||||||
| D | 2024-02-22 | BRKR | Bruker Corp | Prause Burkhard | Pres, CEO, BRUKER BEST | S - Sale+OE | $83.30 | -15,319 | 17,065 | -47% | -$1,276,073 | |||||
2024-02-22 | ILMN | Illumina, Inc. | Thaysen Jacob | CEO | P - Purchase | $135.29 | +7,330 | 14,861 | +97% | +$991,672 | ||||||
| D | 2024-02-22 | SEER | Seer, Inc. | Kogan Elona | GC | S - Sale+OE | $1.58 | -12,684 | 273,142 | -4% | -$20,024 | |||||
| D | 2024-02-22 | SEER | Seer, Inc. | Horn David R. | Pres, CFO | S - Sale+OE | $1.58 | -12,684 | 480,511 | -3% | -$20,024 | |||||
2024-02-16 | PACB | Pacific Biosciences of California, Inc. | Van Oene Mark | See Remarks | S - Sale | $5.96 | -33,560 | 876,611 | -4% | -$199,950 | ||||||
2024-02-16 | PACB | Pacific Biosciences of California, Inc. | Eidel Jeff | See Remarks | S - Sale | $5.96 | -15,498 | 432,032 | -3% | -$92,337 | ||||||
| M | 2024-02-16 | PACB | Pacific Biosciences of California, Inc. | Kim Susan G. | See Remarks | S - Sale | $5.93 | -23,327 | 282,758 | -8% | -$138,403 | |||||
| M | 2024-02-16 | PACB | Pacific Biosciences of California, Inc. | Henry Christian O | See Remarks | S - Sale | $5.94 | -81,017 | 1,005,078 | -7% | -$481,320 | |||||
2024-02-16 | PACB | Pacific Biosciences of California, Inc. | Farmer Michele | See Remarks | S - Sale | $5.96 | -7,562 | 101,164 | -7% | -$45,054 | ||||||
2024-02-15 | TXG | 10X Genomics, Inc. | Saxonov Serge | CEO | S - Sale | $48.87 | -5,000 | 1,050,948 | 0% | -$244,332 | ||||||
2024-02-14 | QTRX | Quanterix Corp | Olson Laurie J | Dir | S - Sale | $24.35 | -1,500 | 15,238 | -9% | -$36,525 | ||||||
| D | 2024-02-12 | MTD | Mettler Toledo International Inc/ | Finney Elisha W | Dir | S - Sale+OE | $1,177.35 | -251 | 316 | -44% | -$295,515 | |||||
| D | 2024-02-12 | MTD | Mettler Toledo International Inc/ | Kelly Michael A | Dir | S - Sale+OE | $1,175.00 | -1,268 | 1,677 | -43% | -$1,489,896 | |||||
2024-02-09 | TXG | 10X Genomics, Inc. | Saxonov Serge | CEO | S - Sale | $49.53 | -1,000 | 1,055,948 | 0% | -$49,530 | ||||||
2024-02-05 | SEER | Seer, Inc. | Horn David R. | Pres, CFO | S - Sale | $1.67 | -3,608 | 328,157 | -1% | -$6,015 | ||||||
| D | 2024-02-05 | RVTY | Revvity, Inc. | Singh Prahlad R. | Please See Remarks | S - Sale+OE | $104.28 | -21,217 | 128,502 | -14% | -$2,212,480 | |||||
| D | 2024-02-05 | RVTY | Revvity, Inc. | Goldberg Joel S | Please See Remarks | S - Sale+OE | $104.28 | -15,475 | 105,444 | -13% | -$1,613,697 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |